Browsing by Author "Dauda A. Dangiwa"

Now showing 1 - 2 of 2

Comparative assessment of Directly Observed Treatment Short-course (DOTS) for tuberculosis patients in a primary and a tertiary health centre in Nigeria
(Journal of PHARMACY AND BIORESOURCES, 2015-03) Benjamin N. Joseph; Comfort N. Sariem; Dauda A. Dangiwa; Shalkur David; Sunday I. Joseph; Daniel Z. Egah
Abstract Nasarawa State, Nigeria has HIV prevalence of 7.5%. This is capable of fueling and worsening the tuberculosis/HIV epidemic. This study compared TB treatment outcomes between a primary health care and a tertiary health center; it assessed the overlap between TB and HIV. A cross-sectional retrospective design was adopted. Data from the directly observed treatment register for 15 months was abstracted from both facilities. A total of 1678 TB patients files were assessed; the tertiary health center accounted for 33% of the TB population while the primary health care center represented two-thirds. Of the 75% of TB patients who had HIV testing, about 48% were HIV positive. Primary health care facility achieved statistically significant outcomes in cured (43%) representing 86.8% of cured outcome within program, p-value 0.000; treatment completed of 46.1% representing 60.4%, p-value 0.000; and had the least case of treatment default, 1.7% which accounted for 18%, p-value 0.000 while the tertiary health facility attained better outcomes in treatment failure and death rates p-value 0.013 and 0.033 respectively. With an overall successful treatment outcome of about 84%; the primary health care center recorded successful treatment outcome of 89% compared to tertiary health facility which achieved 73%. The overlap between TB and HIV was high. Comparatively, treatment outcomes were significantly better at primary health center.
Pharmaceutical care and medication adherence in management of psychosis in a Nigerian tertiary hospital
(Journal of Research in Pharmacy Practice, 2019-08-03) Jonathan Danladi; Kakjing D. Falang; Raymond A. Barde; Nanlok S. Jimam; Dauda A. Dangiwa; Hafsat O. Jimoh
The primary objective of this study is to examine the medication adherence (as a function of pharmaceutical care) and its contributing factors in schizophrenic patients receiving antipsychotic drugs. Methods: This was a cross-sectional study administering a structured questionnaire to 231 patients. Adherence was measured through patient self-reporting. Association between independent variables and adherence to antipsychotics were measured through odds ratios (OR) in the univariate analysis while the best predictors of adherence were determined through the multiple logistic regressions. Findings: Adherence level was found to be 65.8% (95% confidence interval [CI]: 59.3-71.9%). The following factors were identified to be associated with adherence in the univariate analysis: age (OR 1.088), sex (OR 1.231), employment (OR 0.366), marital status (singles, OR 0.022), drug adherence counseling (OR 11.641), twice a day frequency (OR 8.434), alcohol non-intake (OR 1.469), educational level (primary OR 1.9312, secondary OR 11.022, tertiary OR 4.771), occupation (public servant 6.273). In the multivariate analysis, age, three times a day frequency of drug intake, singles and educational levels such as primary, secondary or tertiary school, strongly affected adherence (P < 0.05). Conclusion: Although patients adherence level was high (65.8%), there is a need to emphasize that pharmacists spend more time in counseling and educating patients, especially younger ones on drug adherence before any antipsychotic medications are dispensed. Furthermore, patients should be taught the use of adherence devices such as reminders so that adherence to antipsychotic medications can be optimized.